Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model
The DOI matches its Crossref record.
Abstract
Unlabelled Since 1970, more than 1.4 million individuals worldwide have been screened voluntarily to determine if they are carriers of the mutant gene for Tay-Sachs Disease (TSD). Employing both enzymatic and molecular methods (for optimal sensitivity and specificity) more than 1400 couples have been identified to be at-risk for TSD in their offspring, i.e., both parents heterozygotes. Through prenatal testing of more than 3200 pregnancies, births of over 600 infants with this uniformly fatal neurodegenerative disease have been prevented. In the United States and Canada, the incidence of TSD in the Jewish population has been reduced by more than 90%. More that 100 mutations in the hexosaminidase A gene (the TSD locus) have been identified to date. Some are associated with later onset or more chronic forms of neuronal storage disease. Two mutations cause a carrier-like "pseudo-deficiency" when enzymatic testing is used (false positives). A number of practical, social, and ethical complexities have been identified in this prototypic population-based effort. Educational and counseling components must be provided both before and after screening. Issues of privacy and confidentiality of test results must be addressed. In certain cultures insurability and employment may be involved. The public perception of the biomedical community as advocates for wide-scale testing and screening may be interpreted, in some systems, as conflicts of interest on the part of entrepreneurial scientist…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After 40 years of preconception screening in this population, however, the incidence of TSD has been reduced by more than 90% (2–5).”
From Carrier testing for severe childhood recessive diseases by next-generation sequencing (2011) · cites this paper as [5]
Citations
Cites
Still being checked.
Cited by
Precision Medicine: From Science To Value
Ginsburg, G. S., & Phillips, K. A. (2018) · Health Affairs · doi:10.1377/hlthaff.2017.1624 · Cited by 759
Carrier testing for severe childhood recessive diseases by next-generation sequencing
Bell, C. J., Dinwiddie, D. L., Miller, N. A., Hateley, S. L., Ganusova, E. E., Mudge, J., Langley, R. J., Zhang, L., Lee, C. C., Schilkey, F. D., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001756 · Cited by 706
Population Screening in the Age of Genomic Medicine
Khoury, M. J., McCabe, L. L., & McCabe, E. R. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra013182 · Cited by 456
Ethics and entrepreneurship: A bibliometric study and literature review
Vallaster, C., Kraus, S., Merigó Lindahl, J. M., & Nielsen, A. (2019) · Journal of Business Research · doi:10.1016/j.jbusres.2019.02.050 · Cited by 352
Responsible implementation of expanded carrier screening
Henneman, L., Borry, P., Chokoshvili, D., Cornel, M. C., van El, C. G., Forzano, F., Hall, A., Howard, H. C., Janssens, S., Kayserili, H., et al. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.271 · Cited by 330
Genomic Medicine: A Decade of Successes, Challenges, and Opportunities
McCarthy, J. J., McLeod, H. L., & Ginsburg, G. S. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005785 · Cited by 239
Maegawa, G. H. B., Stockley, T., Tropak, M., Banwell, B., Blaser, S., Kok, F., Giugliani, R., Mahuran, D., & Clarke, J. T. R. (2006) · Pediatrics · doi:10.1542/peds.2006-0588 · Cited by 201
A genetic profile of contemporary Jewish populations
Ostrer, H. (2001) · Nature Reviews Genetics · doi:10.1038/35098506 · Cited by 185
Pyrimethamine as a Potential Pharmacological Chaperone for Late-onset Forms of GM2 Gangliosidosis
Maegawa, G. H. B., Tropak, M., Buttner, J., Stockley, T., Kok, F., Clarke, J. T. R., & Mahuran, D. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609304200 · Cited by 171
The evolving landscape of expanded carrier screening: challenges and opportunities
Kraft, S. A., Duenas, D., Wilfond, B. S., & Goddard, K. A. B. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0273-4 · Cited by 159
Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases
Scott, S. A., Edelmann, L. J., Liu, L., Luo, M., Desnick, R. J., & Kornreich, R. (2010) · Human Mutation · doi:10.1002/humu.21327 · Cited by 164
Genetics and Therapies for GM2 Gangliosidosis
Cachón-González, M. B., Zaccariotto, E., & Cox, T. M. (2018) · Current Gene Therapy · doi:10.2174/1566523218666180404162622 · Cited by 147
Evolving health care through personal genomics
Rehm, H. L. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.162 · Cited by 134
Charria-Ortiz, G. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-70909-3_16 · Cited by 132
Recent developments in genetic/genomic medicine
Horton, R. H., & Lucassen, A. (2019) · Clinical Science · doi:10.1042/cs20180436 · Cited by 141
Su, Y.-N., Hung, C., Lin, S., Chen, F.-Y., Chern, J. P. S., Tsai, C., Chang, T.-S., Yang, C., Li, H., Ho, H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017067 · Cited by 115
Clinical utility of expanded carrier screening: results-guided actionability and outcomes
Taber, K. J., Beauchamp, K. A., Lazarin, G. A., Muzzey, D., Arjunan, A., & Goldberg, J. D. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0321-0 · Cited by 111
Association Between Carrier Screening and Incidence of Cystic Fibrosis
Castellani, C. (2009) · JAMA · doi:10.1001/jama.2009.1758 · Cited by 96
Clinical Utility of Expanded Carrier Screening: Reproductive Behaviors of At‐Risk Couples
Ghiossi, C. E., Goldberg, J. D., Haque, I. S., Lazarin, G. A., & Wong, K. K. (2018) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0160-1 · Cited by 94
Embryo Selection for Cognitive Enhancement: Curiosity or Game‐changer?
Shulman, C., & Bostrom, N. (2014) · Global Policy · doi:10.1111/1758-5899.12123 · Cited by 107
Changing trends in carrier screening for genetic disease in the United States
Nazareth, S. B., Lazarin, G. A., & Goldberg, J. D. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4647 · Cited by 90
Comprehensive Carrier Screening and Molecular Diagnostic Testing for Recessive Childhood Diseases
Kingsmore, S. F. (2012) · PLoS Currents · doi:10.1371/4f9877ab8ffa9 · Cited by 92
Capalbo, A., Poli, M., Riera‐Escamilla, A., Shukla, V., Høffding, M. K., Krausz, C. G., Hoffmann, E. R., & Simón, C. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa044 · Cited by 90
Nemaline myopathy in the Ashkenazi Jewish population is caused by a deletion in the nebulin gene
Anderson, S. L., Ekstein, J., Donnelly, M., Keefe, E. M., Toto, N., LeVoci, L., & Rubin, B. Y. (2004) · Human Genetics · doi:10.1007/s00439-004-1140-8 · Cited by 83
Expanded genetic screening panel for the Ashkenazi Jewish population
Baskovich, B., Hiraki, S., Upadhyay, K., Meyer, P., Carmi, S., Barzilai, N., Darvasi, A., Ozelius, L., Peter, I., Cho, J. H., et al. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.123 · Cited by 80
Carrier Screening for Gaucher Disease: Lessons for Low-Penetrance, Treatable Diseases
Zuckerman, S., Lahad, A., Shmueli, A., Zimran, A., Peleg, L., Orr‐Urtreger, A., Levy‐Lahad, E., & Sagi, M. (2007) · JAMA · doi:10.1001/jama.298.11.1281 · Cited by 92
GENETIC TESTING IN PRIMARY CARE
Burke, W. (2004) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.5.061903.180029 · Cited by 75
Next-generation community genetics for low- and middle-income countries
Kingsmore, S. F., Lantos, J. D., Dinwiddie, D. L., Miller, N., Soden, S. E., Farrow, E., & Saunders, C. (2012) · Genome Medicine · doi:10.1186/gm324 · Cited by 82
Inherited Metabolic Rare Disease
Pàmpols, T. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-9485-8_23 · Cited by 88
Steijvoort, E. V., Chokoshvili, D., Cannon, J. W., Peeters, H., Peeraer, K., Matthijs, G., & Borry, P. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa001 · Cited by 65
The Rise of Genetic Couplehood? A Comparative View of Premarital Genetic Testing
Prainsack, B., & Siegal, G. (2006) · BioSocieties · doi:10.1017/s1745855205050106 · Cited by 68
The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment
Toro, C., Zainab, M., & Tifft, C. J. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136195 · Cited by 63
Cornel, M. C., Rigter, T., Jansen, M. E., & Henneman, L. (2020) · Journal of Community Genetics · doi:10.1007/s12687-020-00488-y · Cited by 70
Xiao, Q., & Lauschke, V. M. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00203-x · Cited by 61
Tay-Sachs disease: current perspectives from Australia
Lew, R. M., Burnett, L., Delatycki, M. B., & Proos, A. (2015) · The Application of Clinical Genetics · doi:10.2147/tacg.s49628 · Cited by 58
Advantages of expanded universal carrier screening: what is at stake?
van der Hout, S., Holtkamp, K. C. A., Henneman, L., de Wert, G. M. W. R., & Dondorp, W. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.125 · Cited by 48
Ready, K. J., Haque, I. S., Srinivasan, B. S., & Marshall, J. R. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.007 · Cited by 51
Evaluation of a Tay‐Sachs Disease screening program
Gason, A., Sheffield, E., Bankier, A., Aitken, M., Metcalfe, S. A., Stewart, K., & Delatycki, M. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00074.x · Cited by 48
Expanded carrier screening in Chinese patients seeking the help of assisted reproductive technology
Xi, Y., Chen, G., Lei, C., Wu, J., Zhang, S., Xiao, M., Zhang, W., Zhang, Y., & Sun, X. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1340 · Cited by 48
What Role for Public Health in Genetics and Vice Versa?
Holtzman, N. A. (2006) · Public Health Genomics · doi:10.1159/000090688 · Cited by 45
Rubinstein, W. S., Jiang, H., Dellefave‐Castillo, L. M., & RADEMAKER, A. W. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e3181afd322 · Cited by 46
Technical standards and guidelines for reproductive screening in the Ashkenazi Jewish population
Monaghan, K. G., Feldman, G. L., Palomaki, G. E., & Spector, E. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31815f6eac · Cited by 43
Pereira, N., Wood, M., Luong, E., Briggs, A., Galloway, M., Maxwell, R. A., & Lindheim, S. R. (2019) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-019-01414-z · Cited by 41
Cannon, J., Steijvoort, E. V., Borry, P., & Chokoshvili, D. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1690456 · Cited by 39
Reproductive options for families at risk of Osteogenesis Imperfecta: a review
Zhytnik, L., Simm, K., Salumets, A., Peters, M., Märtson, A., & Maasalu, K. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01404-w · Cited by 50
The ethics of preconception expanded carrier screening in patients seeking assisted reproduction
de Wert, G. M. W. R., van der Hout, S., Goddijn, M., Vassena, R., Frith, L., Vermeulen, N., Eichenlaub-Ritter, U., Blanchet, V., D’Angelo, A., de Wert, G. M. W. R., et al. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa063 · Cited by 44
Expanded carrier screening: a current survey of physician utilization and attitudes
Briggs, A., Nouri, P. K., Galloway, M., O’Leary, K., Pereira, N., & Lindheim, S. R. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-018-1272-8 · Cited by 34
Clinical aspects of neuropathic lysosomal storage disorders
Jardim, L. B., Villanueva, M. M., de Souza, C. F. M., & Netto, C. B. O. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9079-5 · Cited by 34
“As the result of extensive genetic carrier screening programs in this population, the incidence has been reduced by >90% (Kaback 2000).”
BackgroundGenePING: secure, scalable management of personal genomic data
Adida, B., & Kohane, I. S. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-93 · Cited by 34
The collective burden of childhood dementia: a scoping review
Elvidge, K. L., Christodoulou, J., Farrar, M. A., Tilden, D., Maack, M., Valeri, M., Ellis, M. K., Smith, N. J. C., the Childhood Dementia Working Group, Thorburn, D. R., et al. (2023) · Brain · doi:10.1093/brain/awad242 · Cited by 33
Genetic Epidemiology and Preventive Healthcare in Multiethnic Societies: The Hemoglobinopathies
Giordano, P. C., Harteveld, C. L., & Bakker, E. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110606136 · Cited by 32
Bai, Y., Liu, J., Xu, J., Sun, Y., Li, J., Gao, Y., Liu, L., Jia, C., Kong, X., & Wang, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.878806 · Cited by 32
Attitudes of European Geneticists Regarding Expanded Carrier Screening
Janssens, S., Chokoshvili, D., Vears, D. F., Paepe, A. D., & Borry, P. (2016) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1016/j.jogn.2016.08.012 · Cited by 38
Jahnová, H., Poupětová, H., Jirečková, J., Vlášková, H., Košťálová, E., Mazanec, R., Zumrová, A., Mečíř, P., Mušová, Z., & Magner, M. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09364-3 · Cited by 31
Lew, R. M., Burnett, L., Proos, A., Barlow-Stewart, K. K., Delatycki, M. B., Bankier, A., Aizenberg, H., Field, M. J., Berman, Y. D., Fleischer, R., et al. (2014) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.12632 · Cited by 33
Hussein, N. B., Weng, S. F., Kai, J., Kleijnen, J., & Qureshi, N. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010849.pub3 · Cited by 30
Defining purpose: a key step in genetic test evaluation
Burke, W., Zimmern, R. L., & Kroese, M. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e318156e45b · Cited by 29
Monogenic neurological disorders of sphingolipid metabolism
Sabourdy, F., Astudillo, L. M., Colacios, C., Dubot, P., Mrad, M., Ségui, B., Andrieu‐Abadie, N., & Levade, T. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.01.010 · Cited by 39
Adolescents and genetic testing: what do they think about it?
Harel, A., Abuelo, D. N., & Kazura, A. N. (2003) · Journal of Adolescent Health · doi:10.1016/s1054-139x(03)00135-6 · Cited by 30
Demographic and Experiential Correlates of Public Attitudes Towards Cell‐Free Fetal DNA Screening
Sayres, L. C., Allyse, M. A., Goodspeed, T. A., & Cho, M. K. (2014) · Journal of Genetic Counseling · doi:10.1007/s10897-014-9704-9 · Cited by 27
Genetic screening in the Persian Jewish community: A pilot study
Kaback, M. M., Lopatequi, J. R., Portuges, A. R., Quindipan, C., Pariani, M. J., Salimpour-Davidov, N., & Rimoin, D. L. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181edef5b · Cited by 27
Self-citationYeung, H. H. (2010) · Journal of Pediatric Ophthalmology & Strabismus · doi:10.3928/01913913-20101104-02 · Cited by 27
Langlois, S., BENN, P. A., & Wilkins-Haug, L. E. (2014) · Prenatal Diagnosis · doi:10.1002/pd.4532 · Cited by 31
Prenatal Diagnosis of Congenital Disorders
Wapner, R. J., Jenkins, T. M., & Khalek, N. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4224-2.50019-3 · Cited by 26
Schneider, A. S., Nakagawa, S., Keep, R. B., Dorsainville, D., Charrow, J., Aleck, K. A., Hoffman, J. D., Minkoff, S., Finegold, D. N., Sun, W., et al. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33085 · Cited by 25
Molecular Technologies Open New Clinical Genetic Vistas
Jackson, L., & Pyeritz, R. E. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002064 · Cited by 23
Strovel, E. T., Cusmano‐Ozog, K. P., Wood, T. C., & Yu, C. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2021.12.013 · Cited by 28
Creation of a National, At‐home Model for Ashkenazi Jewish Carrier Screening
Grinzaid, K. A., Page, P. Z., Denton, J. J., & Rogers, J. G. (2014) · Journal of Genetic Counseling · doi:10.1007/s10897-014-9800-x · Cited by 24
Heterozygote Carrier Testing in High Schools Abroad: What are the Lessons for the U.S.?
Ross, L. F. (2006) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.2006.00096.x · Cited by 26
Newborn screening as a model for population screening
McCabe, L. L., & McCabe, E. R. B. (2002) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00005-7 · Cited by 26
Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze
Ferreira, J. C., Schreiber‐Agus, N., Carter, S. M., Klugman, S. D., Gregg, A. R., & Gross, S. J. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.02.001 · Cited by 23
The impact of genomics on public health practice
Burton, H., Jackson, C., & Abubakar, I. I. (2014) · British Medical Bulletin · doi:10.1093/bmb/ldu032 · Cited by 24
Carbohydrate-Processing Enzymes of the Lysosome
Stütz, A., & Wrodnigg, T. M. (2016) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/bs.accb.2016.08.002 · Cited by 25
McGovern, M. M., Benach, M., Wallenstein, S. R., Boone, J., & Lubin, I. M. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-71-psaqap · Cited by 22
Genetic Carrier Screening in the Twenty-first Century
Yao, R., & Goetzinger, K. R. (2016) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2016.01.003 · Cited by 22
Akler, G., Birch, A. H., Schreiber‐Agus, N., Cai, X., Cai, G., Shi, L., Yu, C., Larmore, A. M., Mendiratta‐Vij, G., Elkhoury, L., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1053 · Cited by 20
Lew, R. M., Proos, A., Burnett, L., Delatycki, M. B., Bankier, A., & Fietz, M. J. (2012) · The Medical Journal of Australia · doi:10.5694/mja12.11010 · Cited by 21
27. Future perspectives for Tay-Sachs disease
Desnick, R. J., & Kaback, M. M. (2001) · Advances in genetics · doi:10.1016/s0065-2660(01)44091-0 · Cited by 21
Self-citationHussein, N. B., Henneman, L., Kai, J., & Qureshi, N. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010849.pub4 · Cited by 23
Steinberg, S., Katsanis, S., Moser, A. B., & Cutting, G. R. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.023556 · Cited by 19
Carrier Screening for Genetic Disorders in Individuals of Ashkenazi Jewish Descent
Langlois, S. F., Wilson, R. D., Wilson, R. D., Allen, V. M., Blight, C., Désilets, V. A., Gagnon, A., Langlois, S. F., Reid, G. J., Summers, A. M., et al. (2006) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32131-4 · Cited by 23
Chen, S.-C., Zhou, X., Li, S., Zhao, M., Huang, H., Jia, J., & Xu, C. (2023) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-023-02876-y · Cited by 20
Kaya, N., Al-Owain, M., AbuDheim, N., Al‐Zahrani, J., Çolak, D., Al-Sayed, M., Milanlıoğlu, A., Ozand, P. T., & Alkuraya, F. S. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33932 · Cited by 23
Pharmacogenetics in Jewish populations
Yang, Y., Peter, I., & Scott, S. A. (2014) · Drug metabolism and drug interactions · doi:10.1515/dmdi-2013-0069 · Cited by 18
Preconception and prenatal genetic counselling
Ioannides, A. S. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.04.003 · Cited by 17
Kano, S., Yuan, M., Cardarelli, R. A., Maegawa, G. H. B., Higurashi, N., Gaval‐Cruz, M., Wilson, A. M., Tristan, C., Kondo, M., Chen, Y., et al. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150303110300 · Cited by 15
What's new in prenatal screening and diagnosis?
Bubb, J. A., & Matthews, A. L. (2004) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2004.04.011 · Cited by 17
Founder mutations and rare disease in the Arab world
Marafi, D. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050715 · Cited by 19
Tong, K., He, W., He, Y., Li, X., Hu, L., Hu, H., Lu, G., Lin, G., Dong, C., Zhang, V. W., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.943058 · Cited by 16
SCHOFIELD, D. J., Lee, E., Parmar, J., Kelly, S., Hobbs, M., Laing, N. G., Mumford, J., & Shrestha, R. N. (2023) · Genetics in Medicine · doi:10.1016/j.gim.2023.100813 · Cited by 17
Jalas, C., Anderson, S. L., Laufer, T., Martimucci, K., Bulanov, A. G., Xie, X., Ekstein, J., & Rubin, B. Y. (2011) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2011.03.006 · Cited by 15
Hussein, N. B., Weng, S. F., Kai, J., Kleijnen, J., & Qureshi, N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010849.pub2 · Cited by 15
Expanded carrier screening: too much of a good thing?
Rose, N. C. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4638 · Cited by 16
Laberge, A., Watts, C. A., Porter, K., & Burke, W. (2009) · Public Health Genomics · doi:10.1159/000253122 · Cited by 14
Roe, A. M., & Shur, N. E. (2007) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30121 · Cited by 15
Issa, M. Y., Chechlacz, Z., Stanley, V., George, R. D., McEvoy‐Venneri, J., Belandres, D., Elbendary, H. M., Gaber, K. R., Nabil, A., Abdel‐Hamid, M. S., et al. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-0714-1 · Cited by 13
The importance of preventative medicine in conjunction with modern day genetic studies
Sandler, S., Alfino, L., & Saleem, M. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.04.002 · Cited by 13
Technology challenges in screening single gene disorders
Braun, A. D., Roth, R. B., & McGinniss, M. J. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-003-1343-3 · Cited by 13
Boddington, P., & Hogben, S. (2006) · Health Care Analysis · doi:10.1007/s10728-006-0007-7 · Cited by 13
Preconception carrier screening and preimplantation genetic testing in the infertility management
Caroselli, S., Poli, M., Gatta, V., Stuppia, L., & Capalbo, A. (2024) · Andrology · doi:10.1111/andr.13744 · Cited by 13
Metadata
- Authors
- Kaback, M. M.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Kaback, Michael M.
- Venue
- European Journal of Pediatrics
- Published
- 2000-12
- Volume
- 159
- Issue
- S3
- Pages
- S192-S195
- ISSN
- 0340-6199 (ISSN-L)
- OpenAlex
- W2084004249
- Cited by
- 212
- References
- 0
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 10 · 2023: 12 · 2022: 10 · 2021: 9 · 2020: 13 · 2019: 13 · 2018: 11 · 2017: 4 · 2016: 10 · 2015: 11 · 2014: 15 · 2013: 7 · 2012: 9
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Pediatrics (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Keywords
- Tay-Sachs disease, carrier screening, reproductive counseling, prenatal diagnosis, Jewish population, false positives, privacy and confidentiality, insurance discrimination, employment discrimination, ethics of genetic testing
- MeSH terms
- Adolescent, Adult, beta-N-Acetylhexosaminidases, Canada, Genetic Counseling, Genetic Testing, Humans, Jews, Risk Factors, Tay-Sachs Disease, United States, Hexosaminidase A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.